- Home
- AXSM vs CC Comparison
AXSM vs CC Comparison
Compare AXSM & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | CC |
|---|---|---|
| Founded | 2012 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 2.3B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AXSM | CC |
|---|---|---|
| Price | $152.03 | $12.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 20 | 9 |
| Target Price | ★ $176.00 | $17.00 |
| AVG Volume (30 Days) | 464.4K | ★ 2.1M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $561,263,000.00 | ★ $5,837,000,000.00 |
| Revenue This Year | $66.40 | $3.34 |
| Revenue Next Year | $56.13 | $4.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 65.83 | 0.03 |
| 52 Week Low | $75.56 | $9.13 |
| 52 Week High | $158.57 | $20.12 |
Technical Indicators
Market Signals| Indicator | AXSM | CC |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 47.02 |
| Support Level | $152.41 | $11.68 |
| Resistance Level | $158.56 | $12.40 |
| Average True Range (ATR) | 4.13 | 0.57 |
| MACD | 0.08 | -0.02 |
| Stochastic Oscillator | 55.41 | 25.15 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.